FTO and obesity due to melanocortin 4 receptor deficiency: In addition, FTO has attracted considerable attention as a pharmaceutical target because of the discovery that its overexpression links to the development of metabolic diseases such as obesity and cancers (8, 9, 10, 11, 12, 13).